$SAR
Saratoga Investment Corp Stock $sar

$sar Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000121390023035521 Filed on May 02, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$34.63M	$32.32M	$35.20M
YoY Change	85.4%	70.25%	-50.24%
Cost Of Revenue	$16.85M	$19.82M	$56.79M
YoY Change	83.37%	74.8%	26.33%
Gross Profit	$17.79M	$12.49M	$42.31M
YoY Change	87.37%	63.51%	64.09%
Gross Profit Margin	51.36%	38.66%	120.2%
Selling, General & Admin	$1.820M	$2.864M	$7.264M
YoY Change	12.74%	50.63%	23.48%
% of Gross Profit	10.24%	22.92%	17.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.820M	$2.864M	$63.90M
YoY Change	12.74%	50.63%	986.3%
Operating Profit	$15.97M	$9.629M	-$21.59M
YoY Change	102.67%	67.77%	-208.48%
Interest Expense	-$16.18M	$10.63M	-$7.772M
YoY Change	76.41%	261.2%	-125.55%
% of Operating Profit	-101.34%	110.4%
Other Income/Expense, Net
YoY Change
Pretax Income	-$213.3K	$19.88M	$25.69M
YoY Change	-83.51%	132.06%	-46.36%
Income Tax	$0.00	$676.9K	-$153.0K
% Of Pretax Income		3.41%	-0.6%
Net Earnings	-$213.3K	$19.20M	$24.68M
YoY Change	-85.66%	128.44%	-46.05%
Net Earnings / Revenue	-0.62%	59.42%	70.1%
Basic Earnings Per Share	-$0.02		$2.06
Diluted Earnings Per Share	-$0.02	$1.62	$2.06
COMMON SHARES
Basic Shares Outstanding	11.86M shares	11.89M shares	11.96M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$53.15M	$96.08M	$96.08M
YoY Change	-47.63%	81.72%	81.72%
Cash & Equivalents	$53.15M	$65.75M	$96.08M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$53.61M	$96.88M	$96.88M
YoY Change	-47.36%	81.99%	81.99%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.084B	$116.3M	$972.6M
YoY Change	21.18%	-85.78%	18.95%
Other Assets	$667.9K	$531.3K
YoY Change		108.38%
Total Long-Term Assets	$1.093B	$981.3M	$981.3M
YoY Change	21.37%	19.23%	19.23%
TOTAL ASSETS
Total Short-Term Assets	$53.61M	$96.88M	$96.88M
Total Long-Term Assets	$1.093B	$981.3M	$981.3M
Total Assets	$1.146B	$1.078B	$1.078B
YoY Change	14.39%	23.04%	23.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.52M	$13.58M	$13.58M
YoY Change	33.41%	4.88%	4.88%
Accrued Expenses	$4.486M	$3.653M	$3.653M
YoY Change	-94.38%	-95.29%	-95.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$16.37M	$17.26M	$17.26M
YoY Change	-82.05%	-78.92%	-81.65%
LONG-TERM LIABILITIES
Long-Term Debt	$809.2M	$729.2M	$729.2M
YoY Change	39.83%	66.98%	66.98%
Other Long-Term Liabilities	-$19.56M	-$18.08M	-$18.08M
YoY Change	25.15%	46.6%	46.6%
Total Long-Term Liabilities	$789.6M	$711.1M	$711.1M
YoY Change	40.24%	67.57%	67.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.37M	$17.26M	$17.26M
Total Long-Term Liabilities	$789.6M	$711.1M	$711.1M
Total Liabilities	$808.8M	$731.2M	$731.2M
YoY Change	23.14%	40.49%	40.49%
SHAREHOLDERS EQUITY
Retained Earnings	$16.65M	$25.05M
YoY Change		-9.58%
Common Stock	$320.8M	$321.9M
YoY Change		-1.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$337.5M	$347.0M	$347.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.146B	$1.078B	$1.078B
YoY Change	14.39%	23.04%	23.04%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$213.3K	$19.20M	$24.68M
YoY Change	-85.66%	128.44%	-46.05%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$110.9M	$32.56M	-$130.4M
YoY Change	38.28%	-122.27%	-35.82%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid	$7.135M		$22.67M
YoY Change	34.1%		24.82%
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	67.99M	16.47M	$173.6M
YoY Change	-47.22%	-70.05%	-23.22%
NET CHANGE
Cash From Operating Activities	-110.9M	32.56M	-$130.4M
Cash From Investing Activities
Cash From Financing Activities	67.99M	16.47M	$173.6M
Net Change In Cash	-42.92M	49.03M	$43.21M
YoY Change	-188.28%	-153.76%	88.22%
FREE CASH FLOW
Cash From Operating Activities	-$110.9M	$32.56M	-$130.4M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.32
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.99
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11456631	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11963533	shares
	cef	Latest Nav LatestNav	28.27
	cef	Highest Price Or Bid HighestPriceOrBid	26.95
	cef	Lowest Price Or Bid LowestPriceOrBid	22.7
	cef	Highest Price Or Bid Premium Discount To Nav Percent HighestPriceOrBidPremiumDiscountToNavPercent	-0.047	pure
	cef	Lowest Price Or Bid Premium Discount To Nav Percent LowestPriceOrBidPremiumDiscountToNavPercent	-0.197	pure
	cef	Latest Nav LatestNav	28.25
	cef	Highest Price Or Bid HighestPriceOrBid	27.16
	cef	Lowest Price Or Bid LowestPriceOrBid	20.36
	cef	Highest Price Or Bid Premium Discount To Nav Percent HighestPriceOrBidPremiumDiscountToNavPercent	-0.039	pure
	cef	Lowest Price Or Bid Premium Discount To Nav Percent LowestPriceOrBidPremiumDiscountToNavPercent	-0.279	pure
CY2022	sar	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.01
CY2021	sar	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.13
CY2023	sar	Investment Company Dilution Per Share InvestmentCompanyDilutionPerShare	-0.1
CY2020	sar	Investment Company Expenses Ratio Including Incentive Fee InvestmentCompanyExpensesRatioIncludingIncentiveFee	0.0601	pure
CY2019	sar	Investment Company Expenses Ratio Including Incentive Fee InvestmentCompanyExpensesRatioIncludingIncentiveFee	0.03	pure
CY2023	sar	Investment Company Interest And Debt Financing Expenses To Average Net Assets InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets	0.0973	pure
CY2022	sar	Investment Company Interest And Debt Financing Expenses To Average Net Assets InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets	0.0603	pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-02-28
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-28
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	814-00732
CY2023	dei	Entity Registrant Name EntityRegistrantName	SARATOGA INVESTMENT CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-8700615
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	535 Madison Avenue
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2023	dei	City Area Code CityAreaCode	(212)
CY2023	dei	Local Phone Number LocalPhoneNumber	906-7800
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	211100000	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11861318	shares
	cef	Highest Price Or Bid HighestPriceOrBid	27.76
	cef	Lowest Price Or Bid LowestPriceOrBid	22.82
CY2022Q2	cef	Latest Nav LatestNav	28.69
CY2022Q2	cef	Highest Price Or Bid HighestPriceOrBid	28.31
CY2022Q2	cef	Lowest Price Or Bid LowestPriceOrBid	24.98
CY2022Q2	cef	Highest Price Or Bid Premium Discount To Nav Percent HighestPriceOrBidPremiumDiscountToNavPercent	-0.013	pure
CY2022Q2	cef	Lowest Price Or Bid Premium Discount To Nav Percent LowestPriceOrBidPremiumDiscountToNavPercent	-0.129	pure
CY2023	cef	Latest Nav LatestNav	29.17
CY2023	cef	Highest Price Or Bid HighestPriceOrBid	27.77
CY2023	cef	Lowest Price Or Bid LowestPriceOrBid	25.02
CY2023	cef	Highest Price Or Bid Premium Discount To Nav Percent HighestPriceOrBidPremiumDiscountToNavPercent	-0.048	pure
CY2023	cef	Lowest Price Or Bid Premium Discount To Nav Percent LowestPriceOrBidPremiumDiscountToNavPercent	-0.142	pure
CY2021Q2	cef	Latest Nav LatestNav	28.7
CY2021Q2	cef	Highest Price Or Bid HighestPriceOrBid	26.54
CY2021Q2	cef	Lowest Price Or Bid LowestPriceOrBid	22.66
CY2021Q2	cef	Highest Price Or Bid Premium Discount To Nav Percent HighestPriceOrBidPremiumDiscountToNavPercent	-0.075	pure
CY2021Q2	cef	Lowest Price Or Bid Premium Discount To Nav Percent LowestPriceOrBidPremiumDiscountToNavPercent	-0.211	pure
	cef	Latest Nav LatestNav	28.97
	cef	Highest Price Or Bid HighestPriceOrBid	28.9
	cef	Lowest Price Or Bid LowestPriceOrBid	25.7
	cef	Highest Price Or Bid Premium Discount To Nav Percent HighestPriceOrBidPremiumDiscountToNavPercent	-0.002	pure
	cef	Lowest Price Or Bid Premium Discount To Nav Percent LowestPriceOrBidPremiumDiscountToNavPercent	-0.113	pure
	cef	Latest Nav LatestNav	29.17
	cef	Highest Price Or Bid HighestPriceOrBid	29.8
	cef	Lowest Price Or Bid LowestPriceOrBid	27.19
	cef	Highest Price Or Bid Premium Discount To Nav Percent HighestPriceOrBidPremiumDiscountToNavPercent	0.022	pure
	cef	Lowest Price Or Bid Premium Discount To Nav Percent LowestPriceOrBidPremiumDiscountToNavPercent	-0.068	pure
CY2022	cef	Latest Nav LatestNav	29.32
CY2022	cef	Highest Price Or Bid HighestPriceOrBid	29.51
CY2022	cef	Lowest Price Or Bid LowestPriceOrBid	25.2
CY2022	cef	Highest Price Or Bid Premium Discount To Nav Percent HighestPriceOrBidPremiumDiscountToNavPercent	0.006	pure
CY2022	cef	Lowest Price Or Bid Premium Discount To Nav Percent LowestPriceOrBidPremiumDiscountToNavPercent	-0.141	pure
CY2023	cef	Dividend Reinvestment And Cash Purchase Fees DividendReinvestmentAndCashPurchaseFees	0	usd
CY2023	cef	Management Fees Percent ManagementFeesPercent	0.047	pure
CY2023	cef	Incentive Fees Percent IncentiveFeesPercent	0.014	pure
CY2023	cef	Interest Expenses On Borrowings Percent InterestExpensesOnBorrowingsPercent	0.095	pure
CY2023	cef	Other Annual Expenses Percent OtherAnnualExpensesPercent	0.029	pure
CY2023	cef	Total Annual Expenses Percent TotalAnnualExpensesPercent	0.185	pure
CY2022Q1	us-gaap	Interest Receivable InterestReceivable	5093561	usd
CY2022Q1	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	90968	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	30329779	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5612541	usd
CY2023Q1	sar	Net Reserve Of Interest Receivable NetReserveOfInterestReceivable	2217300	usd
CY2023	cef	Expense Example Year01 ExpenseExampleYear01	190	usd
CY2023	cef	Expense Example Years1to3 ExpenseExampleYears1to3	598	usd
CY2023	cef	Expense Example Years1to5 ExpenseExampleYears1to5	1049	usd
CY2023	cef	Expense Example Years1to10 ExpenseExampleYears1to10	2388	usd
CY2023	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2023	dei	Auditor Location AuditorLocation	New York
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	819966208	usd
CY2022Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	654965044	usd
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	828028800	usd
CY2022Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	668358516	usd
CY2023Q1	us-gaap	Investments In And Advances To Affiliates Balance Principal Amount InvestmentsInAndAdvancesToAffiliatesBalancePrincipalAmount	25722320	usd
CY2022Q1	us-gaap	Investments In And Advances To Affiliates Balance Principal Amount InvestmentsInAndAdvancesToAffiliatesBalancePrincipalAmount	46224927	usd
CY2023Q1	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	28305871	usd
CY2022Q1	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	48234124	usd
CY2023Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	120800829	usd
CY2022Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	95058356	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	116255582	usd
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	100974715	usd
CY2023Q1	sar	Amortized Cost Of Investment At Fair Value AmortizedCostOfInvestmentAtFairValue	966489357	usd
CY2022Q1	sar	Amortized Cost Of Investment At Fair Value AmortizedCostOfInvestmentAtFairValue	796248327	usd
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	972590253	usd
CY2022Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	817567355	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65746494	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47257801	usd
CY2022Q1	sar	Net Reserve Of Interest Receivable NetReserveOfInterestReceivable	0	usd
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	8159951	usd
CY2023Q1	sar	Management Fee Receivable ManagementFeeReceivable	363809	usd
CY2022Q1	sar	Management Fee Receivable ManagementFeeReceivable	362549	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	531337	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	254980	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	436551	usd
CY2021	sar	Investment Company Interest And Debt Financing Expenses To Average Net Assets InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets	0.0456	pure
CY2023Q1	us-gaap	Assets Assets	1078158174	usd
CY2022Q1	us-gaap	Assets Assets	876239755	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	32500000	usd
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	12500000	usd
CY2023Q1	sar	Base Management And Incentive Fees Payable BaseManagementAndIncentiveFeesPayable	12114878	usd
CY2022Q1	sar	Base Management And Incentive Fees Payable BaseManagementAndIncentiveFeesPayable	12947025	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2816572	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1249015	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1464343	usd
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	799058	usd
CY2022Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	2820036	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3652936	usd
CY2022Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2801621	usd
CY2023Q1	sar	Directors Fees Payable DirectorsFeesPayable	14932	usd
CY2022Q1	sar	Directors Fees Payable DirectorsFeesPayable	70000	usd
CY2023Q1	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	10935	usd
CY2022Q1	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	263814	usd
CY2022Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	630183	usd
CY2023Q1	us-gaap	Liabilities Liabilities	731200132	usd
CY2022Q1	us-gaap	Liabilities Liabilities	520459232	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11890500	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11890500	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12131350	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12131350	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	11891	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	12131	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	321893806	usd
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	328062246	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	25052345	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	27706146	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	346958042	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	355780523	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1078158174	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	876239755	usd
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	29.18
CY2022Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	29.33
CY2023	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	72677237	usd
CY2022	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	46369544	usd
CY2021	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	41621899	usd
CY2023	sar	Interest Income On Affiliate Investments InterestIncomeOnAffiliateInvestments	4773527	usd
CY2020	sar	Investment Company Interest And Debt Financing Expenses To Average Net Assets InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets	0.0623	pure
CY2022	sar	Interest Income On Affiliate Investments InterestIncomeOnAffiliateInvestments	3308471	usd
CY2019	sar	Investment Company Interest And Debt Financing Expenses To Average Net Assets InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets	0.0805	pure
CY2021	sar	Interest Income On Affiliate Investments InterestIncomeOnAffiliateInvestments	1656263	usd
CY2023	sar	Interest Income On Control Investments InterestIncomeOnControlInvestments	6602594	usd
CY2022	sar	Interest Income On Control Investments InterestIncomeOnControlInvestments	7345691	usd
CY2021	sar	Interest Income On Control Investments InterestIncomeOnControlInvestments	5848980	usd
CY2023	sar	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	359910	usd
CY2022	sar	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	1150695	usd
CY2021	sar	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	2251499	usd
CY2023	sar	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments	416711	usd
CY2021	sar	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments	172626	usd
CY2023	sar	Payment In Kind Interest Income On Control Investments PaymentInKindInterestIncomeOnControlInvestments	386889	usd
CY2022	sar	Payment In Kind Interest Income On Control Investments PaymentInKindInterestIncomeOnControlInvestments	327171	usd
CY2021	sar	Payment In Kind Interest Income On Control Investments PaymentInKindInterestIncomeOnControlInvestments	162658	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	85216868	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	58501572	usd
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	51713925	usd
CY2023	sar	Interest From Cash And Cash Equivalents InterestFromCashAndCashEquivalents	1368489	usd
CY2022	sar	Interest From Cash And Cash Equivalents InterestFromCashAndCashEquivalents	3584	usd
CY2021	sar	Interest From Cash And Cash Equivalents InterestFromCashAndCashEquivalents	14609	usd
CY2023	sar	Management Fee Income ManagementFeeIncome	3269820	usd
CY2022	sar	Management Fee Income ManagementFeeIncome	3262591	usd
CY2021	sar	Management Fee Income ManagementFeeIncome	2507626	usd
CY2023	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	2720272	usd
CY2022	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	1925791	usd
CY2021	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	158045	usd
CY2023	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	3585061	usd
CY2022	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	4307647	usd
CY2021	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	2157405	usd
CY2023	us-gaap	Other Income OtherIncome	2943610	usd
CY2022	us-gaap	Other Income OtherIncome	2739372	usd
CY2021	us-gaap	Other Income OtherIncome	1098646	usd
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	99104120	usd
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	70740557	usd
CY2021	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	57650256	usd
CY2023	us-gaap	Interest And Debt Expense InterestAndDebtExpense	33498489	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	19880693	usd
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	13587201	usd
CY2023	us-gaap	Management Fee Expense ManagementFeeExpense	16423960	usd
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense	11901729	usd
CY2021	us-gaap	Management Fee Expense ManagementFeeExpense	9098495	usd
CY2023	sar	Incentive Management Fees Expense Benefit IncentiveManagementFeesExpenseBenefit	5057117	usd
CY2022	sar	Incentive Management Fees Expense Benefit IncentiveManagementFeesExpenseBenefit	11794208	usd
CY2021	sar	Incentive Management Fees Expense Benefit IncentiveManagementFeesExpenseBenefit	4903499	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	1812259	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1378134	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	1705942	usd
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	3160417	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	2906250	usd
CY2021	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	2545833	usd
CY2023	us-gaap	General Insurance Expense GeneralInsuranceExpense	347483	usd
CY2022	us-gaap	General Insurance Expense GeneralInsuranceExpense	348671	usd
CY2021	us-gaap	General Insurance Expense GeneralInsuranceExpense	285529	usd
CY2023	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	360000	usd
CY2022	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	335596	usd
CY2021	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	290000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2328672	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1661932	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1428293	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-152956	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-39649	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	667	usd
CY2023	sar	Excise Tax Expense ExciseTaxExpense	1067532	usd
CY2022	sar	Excise Tax Expense ExciseTaxExpense	630183	usd
CY2021	sar	Excise Tax Expense ExciseTaxExpense	691672	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	63902973	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	50797747	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	34537131	usd
CY2023	us-gaap	Net Investment Income NetInvestmentIncome	35201147	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	19942810	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	23113125	usd
CY2023	sar	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments	7446596	usd
CY2022	sar	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments	6209737	usd
CY2021	sar	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments	22207	usd
CY2022	sar	Affiliate Investments AffiliateInvestments	7328457	usd
CY2021	sar	Affiliate Investments AffiliateInvestments	-8726013	usd
CY2022	sar	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments	-139867	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7446596	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	13398327	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-8703806	usd
CY2023	sar	Income Tax Provision Benefit From Realized Gain Loss On Investments IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments	548568	usd
CY2022	sar	Income Tax Provision Benefit From Realized Gain Loss On Investments IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments	-2886444	usd
CY2021	sar	Income Tax Provision Benefit From Realized Gain Loss On Investments IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments	-3895354	usd
CY2023	sar	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-5330880	usd
CY2022	sar	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	14775190	usd
CY2021	sar	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-3817921	usd
CY2023	sar	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	574354	usd
CY2022	sar	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	-26836	usd
CY2021	sar	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	7549096	usd
CY2023	sar	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	-10461606	usd
CY2022	sar	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	2271639	usd
CY2021	sar	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	1235147	usd
CY2023	sar	Net Change In Unrealized Appreciationdepreciation On Investments NetChangeInUnrealizedAppreciationdepreciationOnInvestments	-15218132	usd
CY2022	sar	Net Change In Unrealized Appreciationdepreciation On Investments NetChangeInUnrealizedAppreciationdepreciationOnInvestments	17019993	usd
CY2021	sar	Net Change In Unrealized Appreciationdepreciation On Investments NetChangeInUnrealizedAppreciationdepreciationOnInvestments	4966322	usd
CY2023	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	1715333	usd
CY2022	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	-694908	usd
CY2021	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	574634	usd
CY2023	sar	Net Realized And Unrealized Gainloss On Investments NetRealizedAndUnrealizedGainlossOnInvestments	-8938301	usd
CY2022	sar	Net Realized And Unrealized Gainloss On Investments NetRealizedAndUnrealizedGainlossOnInvestments	28226784	usd
CY2021	sar	Net Realized And Unrealized Gainloss On Investments NetRealizedAndUnrealizedGainlossOnInvestments	-8207472	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1587083	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2434410	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-128617	usd
CY2023	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	24675763	usd
CY2022	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	45735184	usd
CY2021	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	14777036	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.06
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.99
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.32
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11963533	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11456631	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11188629	shares
CY2023	us-gaap	Net Investment Income NetInvestmentIncome	35201147	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	19942810	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	23113125	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7446596	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	13398327	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-8703806	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1587083	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2434410	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-128617	usd
CY2023	sar	Income Tax Provision Benefit From Realized Gain Loss On Investments IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments	548568	usd
CY2022	sar	Income Tax Provision Benefit From Realized Gain Loss On Investments IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments	-2886444	usd
CY2021	sar	Income Tax Provision Benefit From Realized Gain Loss On Investments IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments	-3895354	usd
CY2023	sar	Net Change In Unrealized Appreciationdepreciation On Investments NetChangeInUnrealizedAppreciationdepreciationOnInvestments	-15218132	usd
CY2022	sar	Net Change In Unrealized Appreciationdepreciation On Investments NetChangeInUnrealizedAppreciationdepreciationOnInvestments	17019993	usd
CY2021	sar	Net Change In Unrealized Appreciationdepreciation On Investments NetChangeInUnrealizedAppreciationdepreciationOnInvestments	4966322	usd
CY2023	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	1715333	usd
CY2022	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	-694908	usd
CY2021	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	574634	usd
CY2023	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	24675763	usd
CY2022	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	45735184	usd
CY2021	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	14777036	usd
CY2023	sar	Investment Company Distribution To Shareholders InvestmentCompanyDistributionToShareholders	-27313402	usd
CY2022	sar	Investment Company Distribution To Shareholders InvestmentCompanyDistributionToShareholders	-22033235	usd
CY2021	sar	Investment Company Distribution To Shareholders InvestmentCompanyDistributionToShareholders	-13746998	usd
CY2023	sar	Net Decrease In Net Assets From Shareholder Distributions NetDecreaseInNetAssetsFromShareholderDistributions	-27313402	usd
CY2022	sar	Net Decrease In Net Assets From Shareholder Distributions NetDecreaseInNetAssetsFromShareholderDistributions	-22033235	usd
CY2021	sar	Net Decrease In Net Assets From Shareholder Distributions NetDecreaseInNetAssetsFromShareholderDistributions	-13746998	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26835203	usd
CY2023	sar	Investment Company Dividend Distributions InvestmentCompanyDividendDistributions	4648262	usd
CY2022	sar	Investment Company Dividend Distributions InvestmentCompanyDividendDistributions	3875206	usd
CY2021	sar	Investment Company Dividend Distributions InvestmentCompanyDividendDistributions	2481084	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10824340	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2545037	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3608459	usd
CY2023	sar	Investment Company Capital Share Transactions Repurchase Fees InvestmentCompanyCapitalShareTransactionsRepurchaseFees	8764	usd
CY2022	sar	Investment Company Capital Share Transactions Repurchase Fees InvestmentCompanyCapitalShareTransactionsRepurchaseFees	1992	usd
CY2021	sar	Investment Company Capital Share Transactions Repurchase Fees InvestmentCompanyCapitalShareTransactionsRepurchaseFees	3746	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	270576	usd
CY2023	sar	Net Increase Decrease In Net Assets From Capital Share Transactions NetIncreaseDecreaseInNetAssetsFromCapitalShareTransactions	-6184842	usd
CY2022	sar	Net Increase Decrease In Net Assets From Capital Share Transactions NetIncreaseDecreaseInNetAssetsFromCapitalShareTransactions	27892804	usd
CY2021	sar	Net Increase Decrease In Net Assets From Capital Share Transactions NetIncreaseDecreaseInNetAssetsFromCapitalShareTransactions	-1131121	usd
CY2023	us-gaap	Investment Company Net Assets Period Increase Decrease InvestmentCompanyNetAssetsPeriodIncreaseDecrease	-8822481	usd
CY2022	us-gaap	Investment Company Net Assets Period Increase Decrease InvestmentCompanyNetAssetsPeriodIncreaseDecrease	51594753	usd
CY2021	us-gaap	Investment Company Net Assets Period Increase Decrease InvestmentCompanyNetAssetsPeriodIncreaseDecrease	-101083	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	355780523	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	304185770	usd
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	304286853	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	346958042	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	355780523	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	304185770	usd
CY2023	us-gaap	Profit Loss ProfitLoss	24675763	usd
CY2022	us-gaap	Profit Loss ProfitLoss	45735184	usd
CY2021	us-gaap	Profit Loss ProfitLoss	14777036	usd
CY2023	sar	Paymentinkind And Other Adjustments To Cost PaymentinkindAndOtherAdjustmentsToCost	1882734	usd
CY2022	sar	Paymentinkind And Other Adjustments To Cost PaymentinkindAndOtherAdjustmentsToCost	349292	usd
CY2021	sar	Paymentinkind And Other Adjustments To Cost PaymentinkindAndOtherAdjustmentsToCost	973606	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1816934	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	2043088	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1390128	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3587139	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2164761	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1372662	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1587083	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2434410	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-128617	usd
CY2023	sar	Income Tax Expensebenefit1 IncomeTaxExpensebenefit1	-152956	usd
CY2022	sar	Income Tax Expensebenefit1 IncomeTaxExpensebenefit1	21260	usd
CY2021	sar	Income Tax Expensebenefit1 IncomeTaxExpensebenefit1	667	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7446596	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	13398327	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-8703806	usd
CY2023	sar	Net Change In Unrealized Appreciationdepreciation On Investments NetChangeInUnrealizedAppreciationdepreciationOnInvestments	-15218132	usd
CY2022	sar	Net Change In Unrealized Appreciationdepreciation On Investments NetChangeInUnrealizedAppreciationdepreciationOnInvestments	17019993	usd
CY2021	sar	Net Change In Unrealized Appreciationdepreciation On Investments NetChangeInUnrealizedAppreciationdepreciationOnInvestments	4966322	usd
CY2023	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	1715333	usd
CY2022	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	-694908	usd
CY2021	us-gaap	Investment Company Deferred Income Tax Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation	574634	usd
CY2023	sar	Proceeds From Sales And Repayments Of Investments ProceedsFromSalesAndRepaymentsOfInvestments	222215062	usd
CY2022	sar	Proceeds From Sales And Repayments Of Investments ProceedsFromSalesAndRepaymentsOfInvestments	226931104	usd
CY2021	sar	Proceeds From Sales And Repayments Of Investments ProceedsFromSalesAndRepaymentsOfInvestments	130259061	usd
CY2023	sar	Purchases Of Investment PurchasesOfInvestment	385075296	usd
CY2022	sar	Purchases Of Investment PurchasesOfInvestment	458073629	usd
CY2021	sar	Purchases Of Investment PurchasesOfInvestment	202260764	usd
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	3066390	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	869931	usd
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-586826	usd
CY2023	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-90968	usd
CY2022	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-2628032	usd
CY2021	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	2719000	usd
CY2023	sar	Increase Decrease In Management And Incentive Fee Receivable IncreaseDecreaseInManagementAndIncentiveFeeReceivable	1260	usd
CY2022	sar	Increase Decrease In Management And Incentive Fee Receivable IncreaseDecreaseInManagementAndIncentiveFeeReceivable	327905	usd
CY2021	sar	Increase Decrease In Management And Incentive Fee Receivable IncreaseDecreaseInManagementAndIncentiveFeeReceivable	-237563	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	276357	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-692335	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	265997	usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	436551	usd
CY2023	sar	Increase Decrease In Base Management And Incentive Fees Payable IncreaseDecreaseInBaseManagementAndIncentiveFeesPayable	832147	usd
CY2022	sar	Increase Decrease In Base Management And Incentive Fees Payable IncreaseDecreaseInBaseManagementAndIncentiveFeesPayable	-6390351	usd
CY2021	sar	Increase Decrease In Base Management And Incentive Fees Payable IncreaseDecreaseInBaseManagementAndIncentiveFeesPayable	9243423	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	665285	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-951208	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	37109	usd
CY2023	sar	Increase Decrease In Current Tax Payable IncreaseDecreaseInCurrentTaxPayable	2820036	usd
CY2022	sar	Increase Decrease In Current Tax Payable IncreaseDecreaseInCurrentTaxPayable	-2820036	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	851315	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	155837	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	411742	usd
CY2023	sar	Increase Decrease In Directors Fees Payable IncreaseDecreaseInDirectorsFeesPayable	55068	usd
CY2022	sar	Increase Decrease In Directors Fees Payable IncreaseDecreaseInDirectorsFeesPayable	500	usd
CY2021	sar	Increase Decrease In Directors Fees Payable IncreaseDecreaseInDirectorsFeesPayable	-9000	usd
CY2023	sar	Increase Decrease In Excise Tax Payable IncreaseDecreaseInExciseTaxPayable	630183	usd
CY2022	sar	Increase Decrease In Excise Tax Payable IncreaseDecreaseInExciseTaxPayable	61489	usd
CY2021	sar	Increase Decrease In Excise Tax Payable IncreaseDecreaseInExciseTaxPayable	-691672	usd
CY2023	sar	Increase Decrease In Due To Manager IncreaseDecreaseInDueToManager	252879	usd
CY2022	sar	Increase Decrease In Due To Manager IncreaseDecreaseInDueToManager	15251	usd
CY2021	sar	Increase Decrease In Due To Manager IncreaseDecreaseInDueToManager	264777	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-130373839	usd
CY2023	sar	Investment Company Total Expense To Average Net Assets InvestmentCompanyTotalExpenseToAverageNetAssets	0.1891	pure
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-203133627	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-62346410	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	113000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	135000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	41000000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	76000000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	95500000	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	33000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	223875000	usd
CY2022	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	250000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	63125000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	43125000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	60000000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	10135986	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	10008424	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3435749	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	26835203	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	22665140	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	18158029	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	11265914	usd
CY2023	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	10824340	usd
CY2022	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	2545037	usd
CY2021	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	3608459	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-8764	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1992	usd
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3746	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	270576	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	173579770	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	226088895	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	52811132	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	43205931	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	22955268	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-9535278	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52870342	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29915074	usd
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39450352	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	96076273	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52870342	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29915074	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	28904198	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	17560094	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	11802800	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2770984	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1355083	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4140241	usd
CY2023	sar	Paymentinkind Interest Income And Other Adjustments To Cost PaymentinkindInterestIncomeAndOtherAdjustmentsToCost	-1882734	usd
CY2022	sar	Paymentinkind Interest Income And Other Adjustments To Cost PaymentinkindInterestIncomeAndOtherAdjustmentsToCost	-349292	usd
CY2022	sar	Investment Company Total Expense To Average Net Assets InvestmentCompanyTotalExpenseToAverageNetAssets	0.1609	pure
CY2021	sar	Paymentinkind Interest Income And Other Adjustments To Cost PaymentinkindInterestIncomeAndOtherAdjustmentsToCost	-973606	usd
CY2023	sar	Net Accretion Of Discount On Investments NetAccretionOfDiscountOnInvestments	1816934	usd
CY2022	sar	Net Accretion Of Discount On Investments NetAccretionOfDiscountOnInvestments	2043088	usd
CY2021	sar	Net Accretion Of Discount On Investments NetAccretionOfDiscountOnInvestments	1390128	usd
CY2023	sar	Amortization Of Deferred Debt Financing Costs AmortizationOfDeferredDebtFinancingCosts	3587139	usd
CY2022	sar	Amortization Of Deferred Debt Financing Costs AmortizationOfDeferredDebtFinancingCosts	2164761	usd
CY2021	sar	Amortization Of Deferred Debt Financing Costs AmortizationOfDeferredDebtFinancingCosts	1372662	usd
CY2023	sar	Stock Dividend Distribution StockDividendDistribution	4648262	usd
CY2022	sar	Stock Dividend Distribution StockDividendDistribution	3875206	usd
CY2021	sar	Stock Dividend Distribution StockDividendDistribution	2481084	usd
CY2023Q1	sar	Money Market Shares MoneyMarketShares	96076273	shares
CY2023Q1	us-gaap	Investment Owned Restricted Cost InvestmentOwnedRestrictedCost	96076273	usd
CY2023Q1	us-gaap	Financial Instruments Owned Principal Investments At Fair Value FinancialInstrumentsOwnedPrincipalInvestmentsAtFairValue	96076273	usd
CY2023Q1	sar	Investment Owned Percentage InvestmentOwnedPercentage	0.277	pure
CY2022Q1	sar	Money Market Shares MoneyMarketShares	52870342	shares
CY2022Q1	us-gaap	Investment Owned Restricted Cost InvestmentOwnedRestrictedCost	52870342	usd
CY2022Q1	us-gaap	Financial Instruments Owned Principal Investments At Fair Value FinancialInstrumentsOwnedPrincipalInvestmentsAtFairValue	52870342	usd
CY2022Q1	sar	Investment Owned Percentage InvestmentOwnedPercentage	0.149	pure
CY2023	sar	Principal Of A Loan PrincipalOfALoan	175000000	usd
CY2023Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.001	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates in the Preparation of Financial Statements</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023	sar	Aggregate Value Of Total Assets Percentage AggregateValueOfTotalAssetsPercentage	0.05	pure
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	65746494	usd
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	47257801	usd
CY2021Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	18828047	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	30329779	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5612541	usd
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11087027	usd
CY2023Q1	sar	Total Cash And Cash Equivalents And Cash And Cashs Equivalens Reserve Accounts TotalCashAndCashEquivalentsAndCashAndCashsEquivalensReserveAccounts	96076273	usd
CY2022Q1	sar	Total Cash And Cash Equivalents And Cash And Cashs Equivalens Reserve Accounts TotalCashAndCashEquivalentsAndCashAndCashsEquivalensReserveAccounts	52870342	usd
CY2021Q1	sar	Total Cash And Cash Equivalents And Cash And Cashs Equivalens Reserve Accounts TotalCashAndCashEquivalentsAndCashAndCashsEquivalensReserveAccounts	29915074	usd
CY2023	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Transactions and Income Recognition</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts over the life of the investment and amortization of premiums on investments up to the earliest call date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At February 28, 2023 our investment in one portfolio company was on non-accrual status with a fair value of approximately $9.8 million, or 1.0% of the fair value of our portfolio. At February 28, 2022, there were no investments on non-accrual status.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325, <i>Investments-Other, Beneficial Interests in Securitized Financial Assets</i>, (“ASC 325”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatus	9800000	usd
CY2023	sar	Fair Value Of Our Portfolio Percentage FairValueOfOurPortfolioPercentage	0.01	pure
CY2023	us-gaap	Revenue Recognition Dividends RevenueRecognitionDividends	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend Income </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend income is recorded in the consolidated statements of operations when earned.</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"> </p>
CY2023	sar	Minimum Distribute Percent To Qualify Ric MinimumDistributePercentToQualifyRIC	0.90	pure
CY2023	sar	Nondeductible Us Federal Excise Tax NondeductibleUSFederalExciseTax	0.04	pure
CY2023	sar	Minimum Ordinary Income Net Percentage Of Distribute MinimumOrdinaryIncomeNetPercentageOfDistribute	0.98	pure
CY2023	sar	Minimum Capital Gain Income Net Percentage Of Distribute MinimumCapitalGainIncomeNetPercentageOfDistribute	0.982	pure
CY2023	sar	Percentage Of Federal Excise Tax On Income PercentageOfFederalExciseTaxOnIncome	0.04	pure
CY2023	us-gaap	Taxes Excluding Income And Excise Taxes TaxesExcludingIncomeAndExciseTaxes	1100000	usd
CY2022	us-gaap	Taxes Excluding Income And Excise Taxes TaxesExcludingIncomeAndExciseTaxes	600000	usd
CY2021	us-gaap	Taxes Excluding Income And Excise Taxes TaxesExcludingIncomeAndExciseTaxes	700000	usd
CY2023	sar	Investment Company Dividend Distribution Percentage InvestmentCompanyDividendDistributionPercentage	0.20	pure
CY2023	sar	Investment Company Cash Distribution Percentage InvestmentCompanyCashDistributionPercentage	0.20	pure
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk Management</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.</span></p>
CY2023Q1	sar	First Lien Term Loans FirstLienTermLoans	798534000	usd
CY2023	sar	Second Lien Term Loans SecondLienTermLoans	14936000	usd
CY2023Q1	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	20661000	usd
CY2023	sar	Fair Valueof Structured Finance Securities FairValueofStructuredFinanceSecurities	41362000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	97097000	usd
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	972590000	usd
CY2022Q1	sar	First Lien Term Loans FirstLienTermLoans	631572000	usd
CY2022	sar	Second Lien Term Loans SecondLienTermLoans	44386000	usd
CY2022Q1	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	15931000	usd
CY2022	sar	Fair Valueof Structured Finance Securities FairValueofStructuredFinanceSecurities	38030000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	87648000	usd
CY2022Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	817567000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	805551000	usd
CY2023	sar	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Adjustments To Cost FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAdjustmentsToCost	-1882000	usd
CY2023	sar	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAccretionOfDiscountOnInvestments	1817000	usd
CY2023	sar	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-11851000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	380616000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-222215000	usd
CY2023	sar	Net Realized Gainloss From Investments NetRealizedGainlossFromInvestments	7447000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	959483000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-10254000	usd
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	554313000	usd
CY2022	sar	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Adjustments To Cost FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAdjustmentsToCost	-348000	usd
CY2022	sar	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAccretionOfDiscountOnInvestments	2043000	usd
CY2022	sar	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	18128000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	444950000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-226932000	usd
CY2022	sar	Net Realized Gainloss From Investments NetRealizedGainlossFromInvestments	13397000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	805551000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	22175000	usd
CY2023Q1	sar	Fair Value Measurement FairValueMeasurement	959483000	usd
CY2022Q1	sar	Fair Value Measurement FairValueMeasurement	805551000	usd
CY2023Q1	sar	Investments At Amortized Cost InvestmentsAtAmortizedCost	966489000	usd
CY2023Q1	sar	Amortized Cost Percentage Of Total Portfolio AmortizedCostPercentageOfTotalPortfolio	1	pure
CY2023Q1	sar	Total Investments At Fair Value TotalInvestmentsAtFairValue	972590000	usd
CY2023Q1	sar	Fair Value Percentage Of Total Portfolio FairValuePercentageOfTotalPortfolio	1	pure
CY2022Q1	sar	Investments At Amortized Cost InvestmentsAtAmortizedCost	796248000	usd
CY2022Q1	sar	Amortized Cost Percentage Of Total Portfolio AmortizedCostPercentageOfTotalPortfolio	1	pure
CY2022Q1	sar	Total Investments At Fair Value TotalInvestmentsAtFairValue	817567000	usd
CY2022Q1	sar	Fair Value Percentage Of Total Portfolio FairValuePercentageOfTotalPortfolio	1	pure
CY2023	sar	Clo Member Valuation Model Inputs CLOMemberValuationModelInputs	●Default rate: 2.0% ● Recovery rate: 35%-70% ● Discount rate: 14.0%-22.0% ● Prepayment rate: 20.0% ● Reinvestment rate / price: $97.00 for eighteen months; then L+365bps / $99.00
CY2023	sar	Investment Represents Greater Than Five Percent Of Total Assets InvestmentRepresentsGreaterThanFivePercentOfTotalAssets	0.05	pure
CY2018Q4	sar	Legal Maturity Date LegalMaturityDate	January 2030
CY2018Q4	sar	Additional An Invested AdditionalAnInvested	13800000	usd
CY2021Q1	sar	Additional An Invested AdditionalAnInvested	14000000	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	2600000	usd
CY2021Q3	sar	Outstanding Receivable OutstandingReceivable	2600000	usd
CY2021Q3	sar	Percentage Owned And Managed PercentageOwnedAndManaged	1	pure
CY2021Q3	sar	Percentage Of Management Fee PercentageOfManagementFee	0.001	pure
CY2021	sar	Investment Company Total Expense To Average Net Assets InvestmentCompanyTotalExpenseToAverageNetAssets	0.1311	pure
CY2021Q3	sar	Percentage Subordinated Management Fee PercentageSubordinatedManagementFee	0.004	pure
CY2018Q4	sar	Percentage Of Excess Cash Flow PercentageOfExcessCashFlow	0.20	pure
CY2018Q4	sar	Internal Rate Of Return Paid Percentage InternalRateOfReturnPaidPercentage	0.12	pure
CY2022	us-gaap	Interest Income Other InterestIncomeOther	1200000	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	4900000	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	3500000	usd
CY2023Q1	sar	Investment Principal Balance InvestmentPrincipalBalance	645600000	usd
CY2023	sar	Percentage Of Investments Weighted Average Spread PercentageOfInvestmentsWeightedAverageSpread	0.038	pure
CY2023	sar	Debt Principal Balance DebtPrincipalBalance	611000000	usd
CY2023	sar	Percentage Of Debt Weighted Average Spread PercentageOfDebtWeightedAverageSpread	0.022	pure
CY2023	us-gaap	Effect On Future Cash Flows Amount EffectOnFutureCashFlowsAmount	21200000	usd
CY2023	sar	Investement Of Discount Rate InvestementOfDiscountRate	0.22	pure
CY2008Q1	us-gaap	Other Additional Capital OtherAdditionalCapital	30000000	usd
CY2008Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	13800000	usd
CY2021Q1	us-gaap	Other Additional Capital OtherAdditionalCapital	14000000	usd
CY2023	sar	Received Distributions ReceivedDistributions	77700000	usd
CY2023	us-gaap	Property Management Fee Revenue PropertyManagementFeeRevenue	31900000	usd
CY2023	us-gaap	Noninterest Expense Investment Advisory Fees NoninterestExpenseInvestmentAdvisoryFees	1200000	usd
CY2022Q1	sar	Investment Principal Balance InvestmentPrincipalBalance	660200000	usd
CY2022	sar	Percentage Of Investments Weighted Average Spread PercentageOfInvestmentsWeightedAverageSpread	0.037	pure
CY2022	sar	Debt Principal Balance DebtPrincipalBalance	611000000	usd
CY2022	sar	Percentage Of Debt Weighted Average Spread PercentageOfDebtWeightedAverageSpread	0.022	pure
CY2022	us-gaap	Effect On Future Cash Flows Amount EffectOnFutureCashFlowsAmount	27900000	usd
CY2022	sar	Investement Of Discount Rate InvestementOfDiscountRate	0.15	pure
CY2023	us-gaap	Premiums Earned Net PremiumsEarnedNet	1500000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	100000	usd
CY2023	sar	Unsecured Percentage UnsecuredPercentage	0.07	pure
CY2023	sar	Percentage Of Investment Of Taxable Income PercentageOfInvestmentOfTaxableIncome	0.90	pure
CY2023Q1	sar	Capital In Excess Par Value CapitalInExcessParValue	16000	usd
CY2022Q1	sar	Capital In Excess Par Value CapitalInExcessParValue	-4704000	usd
CY2023Q1	us-gaap	Investment Company Distributable Earnings InvestmentCompanyDistributableEarnings	-16000	usd
CY2022Q1	us-gaap	Investment Company Distributable Earnings InvestmentCompanyDistributableEarnings	4704000	usd
CY2023Q1	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	27313000	usd
CY2022Q1	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	22033000	usd
CY2021Q1	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	13747000	usd
CY2023Q1	sar	Investment Company Distributable Earning InvestmentCompanyDistributableEarning	27313000	usd
CY2022Q1	sar	Investment Company Distributable Earning InvestmentCompanyDistributableEarning	22033000	usd
CY2021Q1	sar	Investment Company Distributable Earning InvestmentCompanyDistributableEarning	13747000	usd
CY2023Q1	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	15500000	usd
CY2022Q1	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	1600000000	usd
CY2022Q1	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	21200000	usd
CY2023Q1	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	1400000000	usd
CY2023	sar	Accumulated Capital Losse AccumulatedCapitalLosse	1580000	usd
CY2022	sar	Accumulated Capital Losse AccumulatedCapitalLosse	1143000	usd
CY2023	sar	Other Temporary Differences OtherTemporaryDifferences	1971000	usd
CY2022	sar	Other Temporary Differences OtherTemporaryDifferences	-1601000	usd
CY2023	us-gaap	Undistributed Earnings Loss From Continuing Operations Available To Common Shareholders Basic UndistributedEarningsLossFromContinuingOperationsAvailableToCommonShareholdersBasic	19771000	usd
CY2022	us-gaap	Undistributed Earnings Loss From Continuing Operations Available To Common Shareholders Basic UndistributedEarningsLossFromContinuingOperationsAvailableToCommonShareholdersBasic	9897000	usd
CY2023	sar	Investment Company Deferred Income Taxes Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxesUnrealizedAppreciation	-15500000	usd
CY2022	sar	Investment Company Deferred Income Taxes Unrealized Appreciation InvestmentCompanyDeferredIncomeTaxesUnrealizedAppreciation	21283000	usd
CY2023	sar	Components Of Accumulated Losses ComponentsOfAccumulatedLosses	4662000	usd
CY2022	sar	Components Of Accumulated Losses ComponentsOfAccumulatedLosses	28436000	usd
CY2023	sar	Shortterm Capital Loss ShorttermCapitalLoss	0	usd
CY2023	sar	Longterm Capital Loss LongtermCapitalLoss	1600000	usd
CY2023	sar	Effective Income Tax Rate Reconciliation At Federal Excise Tax Rate Percent EffectiveIncomeTaxRateReconciliationAtFederalExciseTaxRatePercent	0.04	pure
CY2022	sar	Percentage Of Ordinary Income PercentageOfOrdinaryIncome	0.98	pure
CY2021	sar	Percentage Of Ordinary Income PercentageOfOrdinaryIncome	0.98	pure
CY2022	sar	Percentage Of Capital Gains PercentageOfCapitalGains	0.982	pure
CY2021	sar	Percentage Of Capital Gains PercentageOfCapitalGains	0.982	pure
CY2023	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1100000	usd
CY2022	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	700000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	1600000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	1100000	usd
CY2023	sar	Owned Percentage OwnedPercentage	1	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.21	pure
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2542373	usd
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1991241	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3008829	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1293496	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2350116	usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1946761	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2816572	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1249016	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2400000	usd
CY2023Q1	us-gaap	Investment Owned Unrecognized Unrealized Appreciation Depreciation Net InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet	1700000	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-200000	usd
CY2022Q1	us-gaap	Investment Owned Unrecognized Unrealized Appreciation Depreciation Net InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet	-700000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
CY2021Q1	us-gaap	Investment Owned Unrecognized Unrealized Appreciation Depreciation Net InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet	600000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-473475	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2498515	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-80273	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	327021	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-553748	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2825536	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1467975	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-444628	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	461503	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	99582	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-227737	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	113798	usd
CY2023	sar	Net Deferred Expense NetDeferredExpense	1567557	usd
CY2022	sar	Net Deferred Expense NetDeferredExpense	-672365	usd
CY2021	sar	Net Deferred Expense NetDeferredExpense	575301	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1013809	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2153171	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	575301	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	3700000	usd
CY2023	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	100000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2010Q3	sar	Management Agreement ManagementAgreement	P2Y
CY2023	us-gaap	Management Fee Description ManagementFeeDescription	The base management fee of 1.75% per year is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters.
CY2023	sar	Net Investment Incomes NetInvestmentIncomes	0.20	pure
CY2023	sar	Quarterly Hurdle Rate Measured QuarterlyHurdleRateMeasured	0.01875	pure
CY2023	us-gaap	Incentive Fee Description IncentiveFeeDescription	Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20.0% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter.
CY2023	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.20	pure
CY2023	us-gaap	Management Fee Expense ManagementFeeExpense	16400000	usd
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense	11900000	usd
CY2021	us-gaap	Management Fee Expense ManagementFeeExpense	9100000	usd
CY2023	us-gaap	Incentive Fee Expense IncentiveFeeExpense	6800000	usd
CY2022	us-gaap	Incentive Fee Expense IncentiveFeeExpense	6400000	usd
CY2021	us-gaap	Incentive Fee Expense IncentiveFeeExpense	5400000	usd
CY2023	us-gaap	Payment For Management Fee PaymentForManagementFee	4300000	usd
CY2023	us-gaap	Payment For Incentive Fee PaymentForIncentiveFee	7900000	usd
CY2022	us-gaap	Payment For Management Fee PaymentForManagementFee	3200000	usd
CY2022	us-gaap	Payment For Incentive Fee PaymentForIncentiveFee	9800000	usd
CY2021Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	100000	usd
CY2023	sar	Management Fees Income ManagementFeesIncome	3300000	usd
CY2022	sar	Management Fees Income ManagementFeesIncome	3300000	usd
CY2021	sar	Management Fees Income ManagementFeesIncome	2500000	usd
CY2022Q4	sar	Investment Fair Value InvestmentFairValue	402100000	usd
CY2022Q1	sar	Investment Fair Value InvestmentFairValue	25100000	usd
CY2023Q1	us-gaap	Memberships In Exchanges Owned MembershipsInExchangesOwned	13100000	usd
CY2022Q1	us-gaap	Memberships In Exchanges Owned MembershipsInExchangesOwned	12000000	usd
CY2023	sar	Purchased Of Fair Value Percentage PurchasedOfFairValuePercentage	0.875	pure
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	12250000
CY2023	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.50	pure
CY2023	us-gaap	Debt Instrument Description DebtInstrumentDescription	Our wholly owned SBIC Subsidiaries are able to borrow funds from the SBA against regulatory capital (which approximates equity capital in respective SBIC) and is subject to customary regulatory requirements including but not limited to, a periodic examination by the SBA.
CY2023Q1	sar	Additional Long Term Capital AdditionalLongTermCapital	175000000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	350000000	usd
CY2023	sar	Guaranteed Debentures Description GuaranteedDebenturesDescription	With the third license approval, Saratoga can continue to grow its SBA relationship from $150.0 million to $350.0 million of committed capital.
CY2023Q1	us-gaap	Other Borrowings OtherBorrowings	325000000	usd
CY2023	us-gaap	Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts	1000000	usd
CY2022	us-gaap	Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts	700000	usd
CY2020	sar	Investment Company Total Expense To Average Net Assets InvestmentCompanyTotalExpenseToAverageNetAssets	0.1834	pure
CY2021	us-gaap	Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts	600000	usd
CY2013Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	48300000	usd
CY2013Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.075	pure
CY2015Q2	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	On May 29, 2015, the Company entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which the Company may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market (“ATM”) offering. Prior to the 2020 Notes being redeemed in full, the Company had sold 539,725 units of the 2022 Notes with a principal of $13.5 million at an average price of $25.31 for aggregate net proceeds of $13.4 million (net of transaction costs).
CY2019Q1	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	20000000	usd
CY2019Q1	us-gaap	Unusual Or Infrequent Item Net Of Insurance Proceeds UnusualOrInfrequentItemNetOfInsuranceProceeds	19200000	usd
CY2019Q1	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	600000	usd
CY2019Q1	us-gaap	Common Stock Discount On Shares CommonStockDiscountOnShares	200000	usd
CY2021Q1	us-gaap	Fair Value Option Ineligible Items Aggregate Carrying Amount FairValueOptionIneligibleItemsAggregateCarryingAmount	61200000	usd
CY2021Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0625	pure
CY2021Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	74450000	usd
CY2022Q2	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	Interest on the 6.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.00% per year.
CY2022Q1	us-gaap	Fair Value Option Ineligible Items Aggregate Carrying Amount FairValueOptionIneligibleItemsAggregateCarryingAmount	11500000	usd
CY2023Q1	sar	Indebtedness Indebtedness	1000000000	usd
CY2019Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	74450000	usd
CY2020Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	74450000	usd
CY2021Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.0625	pure
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	43100000	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0725	pure
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	728375000	usd
CY2023Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	108800000	usd
CY2022Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	83400000	usd
CY2023Q1	sar	Off Balance Sheet Arrangements OffBalanceSheetArrangements	108771000	usd
CY2022Q1	sar	Off Balance Sheet Arrangements OffBalanceSheetArrangements	83370000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	65700000	usd
CY2023	sar	Directors Annual Fee DirectorsAnnualFee	70000	usd
CY2023	sar	Board Meeting Attending Fee BoardMeetingAttendingFee	3000	usd
CY2023	sar	Committee Meeting Attending Fee CommitteeMeetingAttendingFee	1500	usd
CY2023	sar	Audit Committee Annual Fee AuditCommitteeAnnualFee	12500	usd
CY2023	sar	Chairman Annual Fee ChairmanAnnualFee	6000	usd
CY2023	sar	Directors Fees And Expenses DirectorsFeesAndExpenses	400000	usd
CY2022	sar	Directors Fees And Expenses DirectorsFeesAndExpenses	300000	usd
CY2021	sar	Directors Fees And Expenses DirectorsFeesAndExpenses	300000	usd
CY2023Q1	sar	Directors Fee Payable DirectorsFeePayable	10000.00	usd
CY2022Q1	sar	Directors Fee Payable DirectorsFeePayable	70000.00	usd
CY2010Q3	us-gaap	Investments In And Advances To Affiliates Balance Shares InvestmentsInAndAdvancesToAffiliatesBalanceShares	986842	shares
CY2010Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	15.2
CY2010Q3	sar	Proceeds Received From Sales ProceedsReceivedFromSales	15000000	usd
CY2010Q3	sar	Total Cash Payment In Lieu Of Shares TotalCashPaymentInLieuOfShares	230	usd
CY2010Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2680842	shares
CY2014Q3	sar	Description Of Repurchase Plan DescriptionOfRepurchasePlan	On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the “Share Repurchase Plan”). On October 7, 2015, our board of directors extended the Share Repurchase Plan for another year and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 400,000 shares of its common stock. On October 5, 2016, our board of directors extended the Share Repurchase Plan for another year to October 15, 2017 and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of its common stock. On October 10, 2017, January 8, 2019 and January 7, 2020, our board of directors extended the Share Repurchase Plan for another year to October 15, 2018, January 15, 2020 and January 15, 2021, respectively, each time leaving the number of shares unchanged at 600,000 shares of its common stock. On May 4, 2020, our board of directors increased the Share Repurchase Plan to 1.3 million shares of common stock. On January 5, 2021 and January 4, 2022, our board of directors extended the Shares Repurchase Plan for another year to January 15, 2022 and January 15, 2023, respectively, each time leaving the number of shares unchanged at 1.3 million shares of common stock. On January 9, 2023, our board of directors extended the Share Repurchase Plan for another year to January 15, 2024, increasing the number of shares to 1.7 million shares of common stock. As of February 28, 2023, the Company purchased 946,627 shares of common stock, at the average price of $21.83 for approximately $20.7 million pursuant to the Share Repurchase Plan. During the three months ended February 28, 2023 the Company purchased 48,594 shares of common stock, at the average price $25.19 for approximately $1.2 million pursuant to the Share Repurchase Plan. During the year ended February 28, 2023, the Company purchased 438,192 shares of common stock, at the average price $24.70 for approximately $10.8 million pursuant to the Share Repurchase Plan.
CY2017Q1	sar	Offer For Sale OfferForSale	30000000	usd
CY2019Q3	sar	Amount Of Common Stock AmountOfCommonStock	70000000	usd
CY2019Q4	sar	Amount Of Common Stock AmountOfCommonStock	130000000	usd
CY2018Q3	sar	Amount Of Common Stock AmountOfCommonStock	1150000	usd
CY2018Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	25
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q3	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million.
CY2018Q3	sar	Excess Of Common Stock ExcessOfCommonStock	172500	shares
CY2021Q3	sar	Offer For Sale OfferForSale	150000000	usd
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4840361	shares
CY2023	sar	Gross Proceeds GrossProceeds	123900000	usd
CY2022Q3	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2022Q3	sar	Stock Based Share Price StockBasedSharePrice	22
CY2023	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	24676000	usd
CY2022	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	45735000	usd
CY2021	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	14777000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11963533	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11456631	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11188629	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.06
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.99
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.32
CY2023	sar	Distribution Percentage DistributionPercentage	0.90	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.69
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.28
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.92
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.03
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.21
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.06
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.9
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.93
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.36
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.4
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.65
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.25
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	3
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.4
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	18.25
CY2023Q1	us-gaap	Dividends Cash DividendsCash	6800000	usd
CY2023Q1	us-gaap	Common Unit Issued CommonUnitIssued	53615	shares
CY2023Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.005	pure
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	24.26
CY2023Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2022Q3	us-gaap	Dividends Cash DividendsCash	5300000	usd
CY2019	sar	Investment Company Total Expense To Average Net Assets InvestmentCompanyTotalExpenseToAverageNetAssets	0.1912	pure
CY2022Q3	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2022Q2	us-gaap	Dividends Cash DividendsCash	5100000	usd
CY2022Q2	sar	Stock Issued For Dividend StockIssuedForDividend	48590	shares
CY2022Q2	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2022Q2	sar	Stock Based Share Price StockBasedSharePrice	22.4
CY2022Q2	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2022Q1	us-gaap	Dividends Cash DividendsCash	5300000	usd
CY2022Q1	sar	Stock Issued For Dividend StockIssuedForDividend	42825	shares
CY2022Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2022Q1	sar	Stock Based Share Price StockBasedSharePrice	25.89
CY2022Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2022Q1	us-gaap	Dividends Cash DividendsCash	5300000	usd
CY2022Q1	sar	Stock Issued For Dividend StockIssuedForDividend	41520	shares
CY2022Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.003	pure
CY2022Q1	sar	Stock Based Share Price StockBasedSharePrice	26.85
CY2022Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2021Q3	us-gaap	Dividends Cash DividendsCash	4900000	usd
CY2021Q3	sar	Stock Issued For Dividend StockIssuedForDividend	38016	shares
CY2021Q3	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.003	pure
CY2021Q3	sar	Stock Based Share Price StockBasedSharePrice	26.77
CY2021Q3	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2021Q2	us-gaap	Dividends Cash DividendsCash	4100000	usd
CY2021Q2	sar	Stock Issued For Dividend StockIssuedForDividend	33100	shares
CY2021Q2	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.003	pure
CY2021Q2	sar	Stock Based Share Price StockBasedSharePrice	25.03
CY2021Q2	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2021Q2	us-gaap	Dividends Cash DividendsCash	3900000	usd
CY2021Q2	sar	Stock Issued For Dividend StockIssuedForDividend	38580	shares
CY2021Q2	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.003	pure
CY2021Q2	sar	Stock Based Share Price StockBasedSharePrice	23.69
CY2021Q2	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2021Q1	us-gaap	Dividends Cash DividendsCash	3800000	usd
CY2021Q1	sar	Stock Issued For Dividend StockIssuedForDividend	41388	shares
CY2021Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2021Q1	sar	Stock Based Share Price StockBasedSharePrice	21.75
CY2021Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2020Q4	us-gaap	Dividends Cash DividendsCash	3800000	usd
CY2020Q4	sar	Stock Issued For Dividend StockIssuedForDividend	45706	shares
CY2020Q4	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2020Q4	sar	Stock Based Share Price StockBasedSharePrice	17.63
CY2020Q4	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2020Q3	us-gaap	Dividends Cash DividendsCash	3700000	usd
CY2020Q3	sar	Stock Issued For Dividend StockIssuedForDividend	47098	shares
CY2020Q3	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2020Q3	sar	Stock Based Share Price StockBasedSharePrice	16.45
CY2020Q3	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2020Q1	us-gaap	Dividends Cash DividendsCash	5400000	usd
CY2020Q1	sar	Stock Issued For Dividend StockIssuedForDividend	35682	shares
CY2020Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.003	pure
CY2020Q1	sar	Stock Based Share Price StockBasedSharePrice	25.44
CY2020Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2019Q3	us-gaap	Dividends Cash DividendsCash	4500000	usd
CY2019Q3	sar	Stock Issued For Dividend StockIssuedForDividend	34575	shares
CY2019Q3	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2019Q3	sar	Stock Based Share Price StockBasedSharePrice	23.34
CY2019Q3	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2019Q2	us-gaap	Dividends Cash DividendsCash	3600000	usd
CY2019Q2	sar	Stock Issued For Dividend StockIssuedForDividend	31545	shares
CY2019Q2	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2019Q2	sar	Stock Based Share Price StockBasedSharePrice	22.65
CY2019Q2	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2019Q1	us-gaap	Dividends Cash DividendsCash	3500000	usd
CY2019Q1	sar	Stock Issued For Dividend StockIssuedForDividend	31240	shares
CY2019Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2019Q1	sar	Stock Based Share Price StockBasedSharePrice	21.36
CY2019Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2019Q1	us-gaap	Dividends Cash DividendsCash	3400000	usd
CY2019Q1	sar	Stock Issued For Dividend StockIssuedForDividend	30796	shares
CY2019Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2019Q1	sar	Stock Based Share Price StockBasedSharePrice	18.88
CY2019Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2018Q3	us-gaap	Dividends Cash DividendsCash	3300000	usd
CY2018Q3	sar	Stock Issued For Dividend StockIssuedForDividend	25862	shares
CY2018Q3	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.003	pure
CY2018Q3	sar	Stock Based Share Price StockBasedSharePrice	22.35
CY2018Q3	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2018Q2	us-gaap	Dividends Cash DividendsCash	2700000	usd
CY2018Q2	sar	Stock Issued For Dividend StockIssuedForDividend	21562	shares
CY2018Q2	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.003	pure
CY2018Q2	sar	Stock Based Share Price StockBasedSharePrice	23.72
CY2018Q2	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2018Q1	us-gaap	Dividends Cash DividendsCash	2600000	usd
CY2018Q1	sar	Stock Issued For Dividend StockIssuedForDividend	25354	shares
CY2018Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2018Q1	sar	Stock Based Share Price StockBasedSharePrice	19.91
CY2018Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2017Q4	us-gaap	Dividends Cash DividendsCash	2500000	usd
CY2017Q4	sar	Stock Issued For Dividend StockIssuedForDividend	25435	shares
CY2017Q4	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2017Q4	sar	Stock Based Share Price StockBasedSharePrice	21.14
CY2017Q4	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2017Q3	us-gaap	Dividends Cash DividendsCash	2200000	usd
CY2017Q3	sar	Stock Issued For Dividend StockIssuedForDividend	33551	shares
CY2017Q3	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.006	pure
CY2017Q3	sar	Stock Based Share Price StockBasedSharePrice	20.19
CY2017Q3	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2017Q2	us-gaap	Dividends Cash DividendsCash	2300000	usd
CY2019	sar	Investment Company Issuance Of Common Stock Above Net Asset Value InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue	0.15
CY2017Q2	sar	Stock Issued For Dividend StockIssuedForDividend	26222	shares
CY2017Q2	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2017Q2	sar	Stock Based Share Price StockBasedSharePrice	20.04
CY2017Q2	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2017Q1	us-gaap	Dividends Cash DividendsCash	2000000	usd
CY2017Q1	sar	Stock Issued For Dividend StockIssuedForDividend	29096	shares
CY2017Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.005	pure
CY2017Q1	sar	Stock Based Share Price StockBasedSharePrice	21.38
CY2017Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2017Q1	us-gaap	Dividends Cash DividendsCash	1600000	usd
CY2017Q1	sar	Stock Issued For Dividend StockIssuedForDividend	50453	shares
CY2017Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.009	pure
CY2017Q1	sar	Stock Based Share Price StockBasedSharePrice	20.25
CY2017Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2016Q4	us-gaap	Dividends Cash DividendsCash	1500000	usd
CY2016Q4	sar	Stock Issued For Dividend StockIssuedForDividend	58548	shares
CY2016Q4	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.01	pure
CY2016Q4	sar	Stock Based Share Price StockBasedSharePrice	17.12
CY2016Q4	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2016Q3	us-gaap	Dividends Cash DividendsCash	700000	usd
CY2016Q3	sar	Stock Issued For Dividend StockIssuedForDividend	24786	shares
CY2016Q3	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2016Q3	sar	Stock Based Share Price StockBasedSharePrice	17.06
CY2016Q3	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2016Q3	us-gaap	Dividends Cash DividendsCash	1500000	usd
CY2016Q3	sar	Stock Issued For Dividend StockIssuedForDividend	58167	shares
CY2016Q3	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.01	pure
CY2016Q3	sar	Stock Based Share Price StockBasedSharePrice	16.32
CY2016Q3	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2016Q2	us-gaap	Dividends Cash DividendsCash	1500000	usd
CY2016Q2	sar	Stock Issued For Dividend StockIssuedForDividend	56728	shares
CY2016Q2	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.01	pure
CY2016Q2	sar	Stock Based Share Price StockBasedSharePrice	15.43
CY2016Q2	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2016Q1	us-gaap	Dividends Cash DividendsCash	1400000	usd
CY2016Q1	sar	Stock Issued For Dividend StockIssuedForDividend	66765	shares
CY2016Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.012	pure
CY2016Q1	sar	Stock Based Share Price StockBasedSharePrice	13.11
CY2016Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2015Q4	us-gaap	Dividends Cash DividendsCash	1100000	usd
CY2015Q4	sar	Stock Issued For Dividend StockIssuedForDividend	61029	shares
CY2015Q4	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.011	pure
CY2015Q4	sar	Stock Based Share Price StockBasedSharePrice	14.53
CY2015Q4	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2016Q3	us-gaap	Dividends Cash DividendsCash	1100000	usd
CY2016Q3	sar	Stock Issued For Dividend StockIssuedForDividend	47861	shares
CY2016Q3	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.009	pure
CY2016Q3	sar	Stock Based Share Price StockBasedSharePrice	15.28
CY2016Q3	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2015Q2	us-gaap	Dividends Cash DividendsCash	3400000	usd
CY2015Q2	sar	Stock Issued For Dividend StockIssuedForDividend	126230	shares
CY2015Q2	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.023	pure
CY2015Q2	sar	Stock Based Share Price StockBasedSharePrice	16.47
CY2015Q2	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2015Q2	us-gaap	Dividends Cash DividendsCash	900000	usd
CY2015Q2	sar	Stock Issued For Dividend StockIssuedForDividend	33766	shares
CY2015Q2	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.006	pure
CY2015Q2	sar	Stock Based Share Price StockBasedSharePrice	16.78
CY2015Q2	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2015Q1	us-gaap	Dividends Cash DividendsCash	800000	usd
CY2015Q1	sar	Stock Issued For Dividend StockIssuedForDividend	26858	shares
CY2015Q1	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.005	pure
CY2015Q1	sar	Stock Based Share Price StockBasedSharePrice	14.97
CY2015Q1	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2014Q4	us-gaap	Dividends Cash DividendsCash	600000	usd
CY2014Q4	sar	Stock Issued For Dividend StockIssuedForDividend	22283	shares
CY2014Q4	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.004	pure
CY2014Q4	sar	Stock Based Share Price StockBasedSharePrice	14.37
CY2014Q4	sar	Percentage Of Weighted Average Tradingprice PercentageOfWeightedAverageTradingprice	0.95	pure
CY2013Q4	us-gaap	Dividends Cash DividendsCash	2500000	usd
CY2013Q4	sar	Stock Issued For Dividend StockIssuedForDividend	649500	shares
CY2013Q4	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.137	pure
CY2013Q4	sar	Aggregate Dividend Amount Percentage AggregateDividendAmountPercentage	0.20	pure
CY2013Q4	sar	Stock Based Share Price StockBasedSharePrice	15.439
CY2012Q4	us-gaap	Dividends Cash DividendsCash	3300000	usd
CY2012Q4	sar	Stock Issued For Dividend StockIssuedForDividend	853455	shares
CY2012Q4	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.22	pure
CY2012Q4	sar	Aggregate Dividend Amount Percentage AggregateDividendAmountPercentage	0.20	pure
CY2012Q4	sar	Stock Based Share Price StockBasedSharePrice	15.444
CY2011Q4	us-gaap	Dividends Cash DividendsCash	2	usd
CY2011Q4	sar	Stock Issued For Dividend StockIssuedForDividend	599584	shares
CY2011Q4	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.18	pure
CY2011Q4	sar	Aggregate Dividend Amount Percentage AggregateDividendAmountPercentage	0.20	pure
CY2011Q4	sar	Stock Based Share Price StockBasedSharePrice	13.117067
CY2010Q4	us-gaap	Dividends Cash DividendsCash	1200000	usd
CY2010Q4	sar	Stock Issued For Dividend StockIssuedForDividend	596235	shares
CY2010Q4	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	0.22	pure
CY2010Q4	sar	Aggregate Dividend Amount Percentage AggregateDividendAmountPercentage	0.10	pure
CY2010Q4	sar	Stock Based Share Price StockBasedSharePrice	17.8049
CY2009Q4	us-gaap	Dividends Cash DividendsCash	2100000	usd
CY2009Q4	sar	Stock Issued For Dividend StockIssuedForDividend	864872.5	shares
CY2009Q4	sar	Common Stock Dividend Rate Percentage CommonStockDividendRatePercentage	1.04	pure
CY2009Q4	sar	Aggregate Dividend Amount Percentage AggregateDividendAmountPercentage	0.137	pure
CY2023	sar	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.17
CY2009Q4	sar	Stock Based Share Price StockBasedSharePrice	1.5099
CY2023Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	2.44
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	29077000	usd
CY2022Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1.92
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	22032000	usd
CY2021Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1.23
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	13747000	usd
CY2020Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	2.21
CY2020Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	20097000	usd
CY2019Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	2.06
CY2019Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	14189000	usd
CY2022Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	29.33
CY2021Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	27.25
CY2020Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	27.13
CY2019Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	23.62
CY2018Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	22.96
CY2019Q1	sar	Net Asset Value Adoption NetAssetValueAdoption	-0.01
CY2023	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	2.94
CY2022	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.74
CY2021	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	2.07
CY2020	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.59
CY2019	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	2.6
CY2023	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.75
CY2022	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	2.46
CY2021	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.74
CY2020	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	4.56
CY2019	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.03
CY2023	sar	Investment Company Realized Losses On Extinguishment Of Debt InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt	-0.13
CY2022	sar	Investment Company Realized Losses On Extinguishment Of Debt InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt	-0.21
CY2021	sar	Investment Company Realized Losses On Extinguishment Of Debt InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt	-0.01
CY2020	sar	Investment Company Realized Losses On Extinguishment Of Debt InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt	-0.17
CY2023	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	2.06
CY2022	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	3.99
CY2021	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.32
CY2020	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	5.98
CY2019	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	2.63
CY2023	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	2.28
CY2022	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.93
CY2021	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.23
CY2020	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	2.21
CY2019	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	2.06
CY2023	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	2.28
CY2022	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.93
CY2021	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.23
CY2020	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	2.21
CY2019	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	2.06
CY2021	sar	Investment Company Dilution Per Share InvestmentCompanyDilutionPerShare	-0.1
CY2020	sar	Investment Company Dilution Per Share InvestmentCompanyDilutionPerShare	-0.26
CY2019	sar	Investment Company Dilution Per Share InvestmentCompanyDilutionPerShare	-0.05
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	29.18
CY2022Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	29.33
CY2021Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	27.25
CY2020Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	27.13
CY2019Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	23.62
CY2023Q1	sar	Net Assets At End Of Periodin Dollars NetAssetsAtEndOfPeriodinDollars	346958042	usd
CY2022Q1	sar	Net Assets At End Of Periodin Dollars NetAssetsAtEndOfPeriodinDollars	355780523	usd
CY2021Q1	sar	Net Assets At End Of Periodin Dollars NetAssetsAtEndOfPeriodinDollars	304185770	usd
CY2020Q1	sar	Net Assets At End Of Periodin Dollars NetAssetsAtEndOfPeriodinDollars	304286853	usd
CY2019Q1	sar	Net Assets At End Of Periodin Dollars NetAssetsAtEndOfPeriodinDollars	180875187	usd
CY2023Q1	us-gaap	Shares Outstanding SharesOutstanding	11890500	shares
CY2022Q1	us-gaap	Shares Outstanding SharesOutstanding	12131350	shares
CY2021Q1	us-gaap	Shares Outstanding SharesOutstanding	11161416	shares
CY2020Q1	us-gaap	Shares Outstanding SharesOutstanding	11217545	shares
CY2019Q1	us-gaap	Shares Outstanding SharesOutstanding	7657156	shares
CY2023Q1	us-gaap-sup	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	27.55
CY2022Q1	us-gaap-sup	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	27.47
CY2021Q1	us-gaap-sup	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	23.08
CY2020Q1	us-gaap-sup	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	22.91
CY2019Q1	us-gaap-sup	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	23.04
CY2023	sar	Investment Company Total Returns Based On Market Value InvestmentCompanyTotalReturnsBasedOnMarketValue	0.1035	pure
CY2022	sar	Investment Company Total Returns Based On Market Value InvestmentCompanyTotalReturnsBasedOnMarketValue	0.2819	pure
CY2021	sar	Investment Company Total Returns Based On Market Value InvestmentCompanyTotalReturnsBasedOnMarketValue	0.0763	pure
CY2020	sar	Investment Company Total Returns Based On Market Value InvestmentCompanyTotalReturnsBasedOnMarketValue	0.0928	pure
CY2019	sar	Investment Company Total Returns Based On Market Value InvestmentCompanyTotalReturnsBasedOnMarketValue	0.1611	pure
CY2023	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0946	pure
CY2022	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1588	pure
CY2021	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0731	pure
CY2020	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.2622	pure
CY2019	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1333	pure
CY2023	sar	Investments Owned Percent Of Net Assets InvestmentsOwnedPercentOfNetAssets	0.1023	pure
CY2022	sar	Investments Owned Percent Of Net Assets InvestmentsOwnedPercentOfNetAssets	0.0605	pure
CY2021	sar	Investments Owned Percent Of Net Assets InvestmentsOwnedPercentOfNetAssets	0.0777	pure
CY2020	sar	Investments Owned Percent Of Net Assets InvestmentsOwnedPercentOfNetAssets	0.0631	pure
CY2019	sar	Investments Owned Percent Of Net Assets InvestmentsOwnedPercentOfNetAssets	0.1122	pure
CY2023	sar	Ratio Of Loss On Extinguishment Of Debt To Average Net Assets RatioOfLossOnExtinguishmentOfDebtToAverageNetAssets	0.0046	pure
CY2022	sar	Ratio Of Loss On Extinguishment Of Debt To Average Net Assets RatioOfLossOnExtinguishmentOfDebtToAverageNetAssets	0.0074	pure
CY2021	sar	Ratio Of Loss On Extinguishment Of Debt To Average Net Assets RatioOfLossOnExtinguishmentOfDebtToAverageNetAssets	0.0004	pure
CY2020	sar	Ratio Of Loss On Extinguishment Of Debt To Average Net Assets RatioOfLossOnExtinguishmentOfDebtToAverageNetAssets	0.0067	pure
CY2023	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0771	pure
CY2022	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0648	pure
CY2021	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.069	pure
CY2020	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.061	pure
CY2019	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0807	pure
CY2023	sar	Investment Company Expenses Ratio Including Incentive Fee InvestmentCompanyExpensesRatioIncludingIncentiveFee	0.0147	pure
CY2022	sar	Investment Company Expenses Ratio Including Incentive Fee InvestmentCompanyExpensesRatioIncludingIncentiveFee	0.0358	pure
CY2021	sar	Investment Company Expenses Ratio Including Incentive Fee InvestmentCompanyExpensesRatioIncludingIncentiveFee	0.0165	pure
CY2023	sar	Portfolio Turnover Rate PortfolioTurnoverRate	0.2405	pure
CY2022	sar	Portfolio Turnover Rate PortfolioTurnoverRate	0.3359	pure
CY2021	sar	Portfolio Turnover Rate PortfolioTurnoverRate	0.2526	pure
CY2020	sar	Portfolio Turnover Rate PortfolioTurnoverRate	0.3682	pure
CY2019	sar	Portfolio Turnover Rate PortfolioTurnoverRate	0.3526	pure
CY2023	sar	Asset Coverage Ratio Per Units AssetCoverageRatioPerUnits	1659	usd
CY2022	sar	Asset Coverage Ratio Per Units AssetCoverageRatioPerUnits	2092	usd
CY2021	sar	Asset Coverage Ratio Per Units AssetCoverageRatioPerUnits	3471	usd
CY2020	sar	Asset Coverage Ratio Per Units AssetCoverageRatioPerUnits	6071	usd
CY2019	sar	Asset Coverage Ratio Per Units AssetCoverageRatioPerUnits	2345	usd
CY2023	sar	Indebtedness Amount IndebtednessAmount	1000	usd
CY2023	us-gaap	Line Of Credit Facility Description LineOfCreditFacilityDescription	The Revolving Credit Facility, SBA Debentures, 7.00% Notes Payable 2025, 4.375% Notes Payable 2026, 4.35% Notes Payable 2026, 7.75% Notes Payable 2025 and 6.25% Notes Payable 2027 are not registered for public trading.
CY2020Q1	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes and are no longer listed on the NYSE.
CY2019Q4	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes and are no longer listed on the NYSE.
CY2021Q3	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	On August 31, 2021, the Company redeemed $60.0 million in aggregate principal amount of the issued and outstanding 6.25% 2025 Notes and, as a result of the full redemption, the 6.25% 2025 Notes are no longer listed on the NYSE.
CY2022Q3	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the $43.1 million in aggregate principal amount of issued and outstanding 7.25% 2025 Notes and are no longer listed on the NYSE.
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10000000	usd
CY2023	us-gaap	Subsequent Event Description SubsequentEventDescription	On April 14, 2023, we issued $50.0 million in aggregate principal amount of 8.50% fixed-rate notes due 2028 (the “8.50% 2028 Notes”) for net proceeds of $48.2 million, based on a public offering price of 100% of par, after deducting underwriting discounts and commissions of approximately $1.6 million and estimated offering expenses of approximately $0.2 million. On April 25, 2023, the underwriters exercised their option in full to purchase an additional $7.5 million in aggregate principal amount of its 8.50% notes due 2028 within 30 days. Net proceeds to the Company were $7.3 million after deducting underwriting commissions of approximately $0.2 million. The 8.50% 2028 Notes are listed on the NYSE under the trading symbol “SAZ” with a par value of $25.00 per share. Interest on the 8.50% 2028 Notes will be paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.50% per year, beginning May 31, 2023. The 8.50% 2028 Notes mature on April 15, 2028 and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at our option. We intend to use the net proceeds of the offering to repay a portion of outstanding indebtedness under the Encina Credit Facility, make investments in middle-market companies in accordance with our investment objective and strategies (including investments made through SBIC III LP) and for general corporate purposes.
CY2023Q1	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent		usd
CY2022Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable		usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes		usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	sar	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments		usd
CY2023	sar	Affiliate Investments AffiliateInvestments		usd
CY2023	sar	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments		usd
CY2021	sar	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.06
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11188629	shares
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	cef	Latest Nav LatestNav
	cef	Highest Price Or Bid Premium Discount To Nav Percent HighestPriceOrBidPremiumDiscountToNavPercent		pure
	cef	Lowest Price Or Bid Premium Discount To Nav Percent LowestPriceOrBidPremiumDiscountToNavPercent		pure
CY2023	cef	Sales Load Percent SalesLoadPercent		pure
CY2023	cef	Other Transaction Expense1 Percent OtherTransactionExpense1Percent		pure
CY2023	cef	Other Transaction Expenses Percent OtherTransactionExpensesPercent		pure
CY2023Q1	us-gaap	Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss		usd
CY2022Q1	us-gaap	Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss		usd
CY2023	sar	Post October Loss Deferred PostOctoberLossDeferred		usd
CY2022	sar	Post October Loss Deferred PostOctoberLossDeferred		usd
CY2023	sar	Undistributed Long Term Gain UndistributedLongTermGain		usd
CY2022	sar	Undistributed Long Term Gain UndistributedLongTermGain		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023Q1	sar	Net Asset Value Adoption NetAssetValueAdoption
CY2022Q1	sar	Net Asset Value Adoption NetAssetValueAdoption
CY2021Q1	sar	Net Asset Value Adoption NetAssetValueAdoption
CY2019	sar	Investment Company Realized Losses On Extinguishment Of Debt InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt
CY2023	sar	Investment Company Issuance Of Common Stock Above Net Asset Value InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue
CY2022	sar	Investment Company Issuance Of Common Stock Above Net Asset Value InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue
CY2021	sar	Investment Company Issuance Of Common Stock Above Net Asset Value InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue
CY2020	sar	Investment Company Issuance Of Common Stock Above Net Asset Value InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue
CY2020	sar	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock
CY2019	sar	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock
CY2022	sar	Investment Company Dilution Per Share InvestmentCompanyDilutionPerShare
CY2019	sar	Ratio Of Loss On Extinguishment Of Debt To Average Net Assets RatioOfLossOnExtinguishmentOfDebtToAverageNetAssets		pure
CY2023	sar	Average Market Value Per Unit Of Revolving Credit Facility AverageMarketValuePerUnitOfRevolvingCreditFacility
CY2022	sar	Average Market Value Per Unit Of Revolving Credit Facility AverageMarketValuePerUnitOfRevolvingCreditFacility
CY2021	sar	Average Market Value Per Unit Of Revolving Credit Facility AverageMarketValuePerUnitOfRevolvingCreditFacility
CY2020	sar	Average Market Value Per Unit Of Revolving Credit Facility AverageMarketValuePerUnitOfRevolvingCreditFacility
CY2019	sar	Average Market Value Per Unit Of Revolving Credit Facility AverageMarketValuePerUnitOfRevolvingCreditFacility
CY2023	sar	Average Market Value Per Unit Of Small Business Administration Debentures Payable AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
CY2022	sar	Average Market Value Per Unit Of Small Business Administration Debentures Payable AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
CY2021	sar	Average Market Value Per Unit Of Small Business Administration Debentures Payable AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
CY2020	sar	Average Market Value Per Unit Of Small Business Administration Debentures Payable AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
CY2019	sar	Average Market Value Per Unit Of Small Business Administration Debentures Payable AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001377936

Files In Submission

Name	View Source	Status
0001213900-23-035521-index-headers.html	Edgar Link	pending
0001213900-23-035521-index.html	Edgar Link	pending
0001213900-23-035521.txt	Edgar Link	pending
0001213900-23-035521-xbrl.zip	Edgar Link	pending
ex23-2_001.jpg	Edgar Link	pending
f10k2023ex21_saratoga.htm	Edgar Link	pending
f10k2023ex23-1_saratoga.htm	Edgar Link	pending
f10k2023ex23-2_saratoga.htm	Edgar Link	pending
f10k2023ex31-1_saratoga.htm	Edgar Link	pending
f10k2023ex31-2_saratoga.htm	Edgar Link	pending
f10k2023ex32-1_saratoga.htm	Edgar Link	pending
f10k2023ex32-2_saratoga.htm	Edgar Link	pending
f10k2023ex4-24_saratoga.htm	Edgar Link	pending
f10k2023_saratoga.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10k2023_saratoga_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sar-20230228.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sar-20230228_cal.xml	Edgar Link	unprocessable
sar-20230228_def.xml	Edgar Link	unprocessable
sar-20230228_lab.xml	Edgar Link	unprocessable
sar-20230228_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SAR
Saratoga Investment Corp Stock $sar

2023 Q2 Form 10-K Financial Statement

#000121390023035521 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SAR Saratoga Investment Corp Stock $sar

2023 Q2 Form 10-K Financial Statement

#000121390023035521 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SAR
Saratoga Investment Corp Stock $sar